CLINICAL AND MORPHOLOGICAL MANIFESTATIONS AND RISK FACTORS OF LUNG DAMAGE IN RHEUMATOID ARTHRITIS

Authors

  • Saidova Muxabbat Muxitdinovna Bukhara State Medical Institute, Republic of Uzbekistan
  • Inoyatullaev Muxriddin Erkinovich Bukhara State Medical Institute, Republic of Uzbekistan

Keywords:

rheumatoid arthritis, lung damage, clinical and morphological manifestations, risk factors, interstitial lung disease, pulmonology

Abstract

The study focuses on the analysis of clinical and morphological manifestations and risk factors for the development of lung lesions in patients with rheumatoid arthritis (RA). Lung damage in RA is a significant clinical complication that leads to a deterioration in the prognosis and quality of life of patients. This study examined the medical data of 300 patients who underwent diagnosis and treatment in the period from 2019 to 2022. The use of radiography, computed tomography, and histological analysis made it possible to identify the main morphological changes in the lungs, such as interstitial disorders and fibrosis, and to assess their correlation with the clinical parameters of the disease. The results indicate a significant role of RA duration, rheumatoid factor level, and anti-CCP antibodies in the development of pulmonary complications. Identifying these risk factors is an important step towards optimizing prevention and treatment strategies for lung damage. The study highlights the need for early diagnosis and an adapted approach to the treatment of RA patients to minimize the risk and severity of pulmonary manifestations.

Downloads

Published

2024-04-17

How to Cite

Muxitdinovna, S. M. ., & Erkinovich, I. M. . (2024). CLINICAL AND MORPHOLOGICAL MANIFESTATIONS AND RISK FACTORS OF LUNG DAMAGE IN RHEUMATOID ARTHRITIS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 120–123. Retrieved from https://inovatus.es/index.php/ejmmp/article/view/2930

Similar Articles

<< < 6 7 8 9 10 11 12 13 14 15 > >> 

You may also start an advanced similarity search for this article.